OVARY NEOPLASM
Clinical trials for OVARY NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new OVARY NEOPLASM trials appear
Sign up with your email to follow new studies for OVARY NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at hard-to-treat cancers
Disease control TerminatedThis study tested a personalized treatment where a patient's own immune cells were modified in a lab to recognize and attack unique markers on their cancer cells. It involved 8 people with advanced solid tumors like lung, pancreatic, or ovarian cancer that had stopped responding …
Matched conditions: OVARY NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Alaunos Therapeutics • Aim: Disease control
Last updated May 17, 2026 06:51 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested a new drug called NUV-868, alone or combined with other cancer drugs (olaparib or enzalutamide), in people with advanced solid tumors like ovarian, pancreatic, prostate, or breast cancer. The main goals were to check safety and find the right dose. The study was…
Matched conditions: OVARY NEOPLASM
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated May 04, 2026 16:31 UTC